Side-by-side comparison of AI visibility scores, market position, and capabilities
Nautilus Biotechnology is building a single-molecule proteomics platform to map and quantify the full human proteome at a scale and sensitivity previously impossible.
Nautilus Biotechnology is a proteomics company founded in 2016 and publicly listed on Nasdaq, developing a revolutionary platform for analyzing proteins at single-molecule resolution. While genomics has transformed medicine through DNA and RNA sequencing, the proteome is the actual functional layer of biology where drug targets, disease biomarkers, and therapeutic mechanisms operate. Nautilus is building a platform that can identify and quantify thousands of proteins simultaneously from tiny biological samples using a fluorescence-based single-molecule detection approach without requiring mass spectrometry. The platform promises to enable proteomics studies at a scale and depth comparable to what next-generation sequencing delivered to genomics, unlocking new insights into disease biology and drug development. Nautilus is in the instrument development phase and targets pharmaceutical research, clinical diagnostics, and academic biology. The company has raised over $250M and is building manufacturing capabilities for a planned commercial instrument launch that could define a new era in proteomics research.
ChromaCode develops HDPCR technology enabling standard PCR instruments to run highly multiplexed molecular diagnostic assays for infectious disease, oncology, and genetic testing at lower cost.
ChromaCode is a molecular diagnostics company developing High-Definition PCR (HDPCR), a breakthrough multiplexing platform that dramatically expands the number of analytes detectable in a single PCR well using standard laboratory instruments. By combining proprietary chemistry with amplitude modulation, multi-spectral encoding, and cloud-based decoding software, HDPCR enables labs to run panels for infectious disease, oncology biomarkers, transplant monitoring, and prenatal testing without expensive new hardware.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.